<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32726472</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5381</ISSN><JournalIssue CitedMedium="Internet"><Volume>178</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>British journal of pharmacology</Title><ISOAbbreviation>Br J Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1353</StartPage><EndPage>1372</EndPage><MedlinePgn>1353-1372</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/bph.15217</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease. ALS patients suffer from a progressive loss of motor neurons, leading to respiratory failure within 3 to 5 years after diagnosis. Available therapies only slow down the disease progression moderately or extend the lifespan by a few months. Epigenetic hallmarks have been linked to the disease, creating an avenue for potential therapeutic approaches. Interference with one class of epigenetic enzymes, histone deacetylases, has been shown to affect neurodegeneration in many preclinical models. Consequently, it is crucial to improve our understanding about histone deacetylases and their inhibitors in (pre)clinical models of ALS. We conclude that selective inhibitors with high tolerability and safety and sufficient blood-brain barrier permeability will be needed to interfere with both epigenetic and non-epigenetic targets of these enzymes. LINKED ARTICLES: This article is part of a themed issue on Neurochemistry in Japan. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.6/issuetoc.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. British Journal of Pharmacology published by John Wiley &amp; Sons Ltd on behalf of British Pharmacological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klingl</LastName><ForeName>Yvonne E</ForeName><Initials>YE</Initials><Identifier Source="ORCID">0000-0003-2779-3357</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, VIB, Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pakravan</LastName><ForeName>Donya</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3165-984X</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, VIB, Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Den Bosch</LastName><ForeName>Ludo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0104-4067</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, VIB, Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FWO/1S50320N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek</Agency><Country/></Grant><Grant><Agency>Amyotrophic Lateral Sclerosis Association</Agency><Country/></Grant><Grant><Agency>Target ALS</Agency><Country/></Grant><Grant><Agency>ALS Liga Belgi&#xeb; (A Cure for ALS)</Agency><Country/></Grant><Grant><Agency>Muscular Dystrophy Association</Agency><Country/></Grant><Grant><Agency>Association Belge contre les Maladies neuro-Musculaires</Agency><Country/></Grant><Grant><Agency>Fondation Thierry Latran</Agency><Country/></Grant><Grant><Agency>KU Leuven</Agency><Country/></Grant><Grant><Agency>Vlaams Instituut voor Biotechnologie</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Pharmacol</MedlineTA><NlmUniqueID>7502536</NlmUniqueID><ISSNLinking>0007-1188</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.5.1.98</RegistryNumber><NameOfSubstance UI="D006655">Histone Deacetylases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057890" MajorTopicYN="N">Epigenomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006655" MajorTopicYN="N">Histone Deacetylases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HDAC</Keyword><Keyword MajorTopicYN="N">HDAC inhibitor</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">histone deacetylase</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32726472</ArticleId><ArticleId IdType="pmc">PMC9327724</ArticleId><ArticleId IdType="doi">10.1111/bph.15217</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alao, J. P. (2007). The regulation of cyclin D1 degradation: Roles in cancer development and the potential for therapeutic invention. Molecular Cancer, 6, 1&#x2013;16. 10.1186/1476-4598-6-24</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-4598-6-24</ArticleId><ArticleId IdType="pmc">PMC1851974</ArticleId><ArticleId IdType="pubmed">17407548</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Chalabi, A. , Van Den Berg, L. H. , &amp; Veldink, J. (2017). Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management. Nature Reviews Neurology, 13(2), 96&#x2013;104. 10.1038/nrneurol.2016.182</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander, S. P. H. , Fabbro, D. , Kelly, E. , Mathie, A. , Peters, J. A. , Veale, E. L. , &#x2026; CGTP Collaborators . (2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes. British Journal of Pharmacology, 176, S297&#x2013;S396. 10.1111/bph.14752</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14752</ArticleId><ArticleId IdType="pmc">PMC6844577</ArticleId><ArticleId IdType="pubmed">31710714</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander, S. P. H. , Kelly, E. , Mathie, A. , Peters, J. A. , Veale, E. L. , Faccenda, E. , &#x2026; CGTP Collaborators . (2019a). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Other Protein Targets. British Journal of Pharmacology, 176, S1&#x2013;S20. 10.1111/bph.14747</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14747</ArticleId><ArticleId IdType="pmc">PMC6844537</ArticleId><ArticleId IdType="pubmed">31710719</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander, S. P. H. , Kelly, E. , Mathie, A. , Peters, J. A. , Veale, E. L. , Armstrong, J. F. , &#x2026; CGTP Collaborators . (2019b). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters. British Journal of Pharmacology, 176, S397&#x2013;S493. 10.1111/bph.14753</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14753</ArticleId><ArticleId IdType="pmc">PMC6844579</ArticleId><ArticleId IdType="pubmed">31710713</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander, S. P. H. , Mathie, A. , Peters, J. A. , Veale, E. L. , Striessnig, J. , Kelly, E. , &#x2026; CGTP Collaborators . (2019). THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology, 176, S142&#x2013;S228. 10.1111/bph.14749</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14749</ArticleId><ArticleId IdType="pmc">PMC6844578</ArticleId><ArticleId IdType="pubmed">31710715</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson, M. K. , St&#xe5;hlberg, A. , Arvidsson, Y. , Olofsson, A. , Semb, H. , Stenman, G. , &#x2026; &#xc5;man, P. (2008). The multifunctional FUS, EWS and TAF15 proto&#x2010;oncoproteins show cell type&#x2010;specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biology, 17, 1&#x2013;17. 10.1186/1471-2121-9-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2121-9-37</ArticleId><ArticleId IdType="pmc">PMC2478660</ArticleId><ArticleId IdType="pubmed">18620564</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen, P. M. (2006). Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Current Neurology and Neuroscience Reports, 6(1), 37&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">16469270</ArticleId></ArticleIdList></Reference><Reference><Citation>Armakola, M. , Higgins, M. J. , Figley, M. D. , Barmada, S. J. , Scarborough, E. A. , Diaz, Z. , &#x2026; Gitler, A. D. (2012). Inhibition of RNA lariat debranching enzyme suppresses TDP&#x2010;43 toxicity in ALS disease models. Nature Genetics, 44(12), 1302&#x2013;1309. 10.1038/ng.2434</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2434</ArticleId><ArticleId IdType="pmc">PMC3510335</ArticleId><ArticleId IdType="pubmed">23104007</ArticleId></ArticleIdList></Reference><Reference><Citation>Arosio, A. , Sala, G. , Rodriguez&#x2010;Menendez, V. , Grana, D. , Gerardi, F. , Lunetta, C. , &#x2026; Tremolizzo, L. (2016). MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients. Molecular and Cellular Neuroscience, 74, 10&#x2013;17. 10.1016/j.mcn.2016.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2016.02.002</ArticleId><ArticleId IdType="pubmed">26921792</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila, A. M. , Burnett, B. G. , Taye, A. A. , Gabanella, F. , Knight, M. A. , Hartenstein, P. , &#x2026; Sumner, C. J. (2007). Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. Journal of Clinical Investigation, 117(3), 659&#x2013;671. 10.1172/JCI29562</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI29562</ArticleId><ArticleId IdType="pmc">PMC1797603</ArticleId><ArticleId IdType="pubmed">17318264</ArticleId></ArticleIdList></Reference><Reference><Citation>Bali, P. , Pranpat, M. , Bradner, J. , Balasis, M. , Fiskus, W. , Guo, F. , &#x2026; Bhalla, K. (2005). Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: A novel basis for antileukemia activity of histone deacetylase inhibitors. Journal of Biological Chemistry, 280(29), 26729&#x2013;26734. 10.1074/jbc.C500186200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc</ArticleId><ArticleId IdType="pubmed">15937340</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardai, F. H. , &amp; D'Mello, S. R. (2011). Selective toxicity by HDAC3 in neurons: Regulation by Akt and GSK3&#x3b2;. Journal of Neuroscience, 31(5), 1746&#x2013;1751. 10.1523/JNEUROSCI.5704-10.2011</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5704-10.2011</ArticleId><ArticleId IdType="pmc">PMC3711464</ArticleId><ArticleId IdType="pubmed">21289184</ArticleId></ArticleIdList></Reference><Reference><Citation>Batulan, Z. , Taylor, D. M. , Aarons, R. J. , Minotti, S. , Doroudchi, M. M. , Nalbantoglu, J. , &amp; Durham, H. D. (2006). Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis. Neurobiology of Disease, 24(2), 213&#x2013;225. 10.1016/j.nbd.2006.06.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.06.017</ArticleId><ArticleId IdType="pubmed">16950627</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar, M. , Wuu, J. , Andersen, P. M. , Atassi, N. , David, W. , Cudkowicz, M. , &amp; Schoenfeld, D. (2018). Randomized, double&#x2010;blind, placebo&#x2010;controlled trial of arimoclomol in rapidly progressive SOD1 ALS. Neurology, 90(7), e565&#x2013;e574. 10.1212/WNL.0000000000004960</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004960</ArticleId><ArticleId IdType="pmc">PMC5818014</ArticleId><ArticleId IdType="pubmed">29367439</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett, S. A. , Tanaz, R. , Cobos, S. N. , &amp; Torrente, M. P. (2019). Epigenetics in amyotrophic lateral sclerosis: A role for histone post&#x2010;translational modifications in neurodegenerative disease. Translational Research, 204, 19&#x2013;30. 10.1016/j.trsl.2018.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2018.10.002</ArticleId><ArticleId IdType="pmc">PMC6331271</ArticleId><ArticleId IdType="pubmed">30391475</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyault, C. , Zhang, Y. , Fritah, S. , Caron, C. , Gilquin, B. , So, H. K. , &#x2026; Khochbin, S. (2007). HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes and Development, 21(17), 2172&#x2013;2181. 10.1101/gad.436407</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.436407</ArticleId><ArticleId IdType="pmc">PMC1950856</ArticleId><ArticleId IdType="pubmed">17785525</ArticleId></ArticleIdList></Reference><Reference><Citation>Broide, R. S. , Redwine, J. M. , Aftahi, N. , Young, W. , Bloom, F. E. , &amp; Winrow, C. J. (2007). Distribution of histone deacetylases 1&#x2013;11 in the rat brain. Journal of Molecular Neuroscience, 31(3), 281&#x2013;287. 10.1385/JMOTORNEURON/31</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/JMOTORNEURON/31</ArticleId><ArticleId IdType="pubmed">17416969</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, R. H. , &amp; Al&#x2010;Chalabi, A. (2017). Amyotrophic lateral sclerosis. New England Journal of Medicine, 377(2), 162&#x2013;172. 10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau, G. , Simonet, T. , Bauch&#xe9;, S. , Mandjee, N. , Malfatti, E. , Girard, E. , &#x2026; Hanta&#xef;, D. (2013). Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: Potential role in reinnervation ability and disease progression. Brain, 136(8), 2359&#x2013;2368. 10.1093/brain/awt164</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt164</ArticleId><ArticleId IdType="pubmed">23824486</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonvicino, D. , Felici, R. , Ranieri, G. , Caramelli, R. , Lapucci, A. , Cavone, L. , &#x2026; Chiarugi, A. (2018). Effects of class II&#x2010;selective histone deacetylase inhibitor on neuromuscular function and disease progression in SOD1&#x2010;ALS mice. Neuroscience, 379, 228&#x2013;238. 10.1016/j.neuroscience.2018.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.03.022</ArticleId><ArticleId IdType="pubmed">29588251</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler, K. V. , Kalin, J. , Brochier, C. , Vistoli, G. , Langley, B. , &amp; Kozikowski, A. P. (2010). Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. Journal of the American Chemical Society, 132(31), 10842&#x2013;10846. 10.1021/ja102758v</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja102758v</ArticleId><ArticleId IdType="pmc">PMC2916045</ArticleId><ArticleId IdType="pubmed">20614936</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassel, J. A. , McDonnell, M. E. , Velvadapu, V. , Andrianov, V. , &amp; Reitz, A. B. (2012). Characterization of a series of 4&#x2010;aminoquinolines that stimulate caspase&#x2010;7 mediated cleavage of TDP&#x2010;43 and inhibit its function. Biochimie, 94(9), 1974&#x2013;1981. 10.1016/j.biochi.2012.05.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2012.05.020</ArticleId><ArticleId IdType="pmc">PMC3402613</ArticleId><ArticleId IdType="pubmed">22659571</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha, J. R. C. , St. Louis, K. J. H. , Tradewell, M. L. , Gentil, B. J. , Minotti, S. , Jaffer, Z. M. , &#x2026; Durham, H. D. (2014). A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo (Cell Stress and Chaperones DOI 10.1007/s12192&#x2010;013&#x2010;0467&#x2010;2). Cell Stress &amp; Chaperones, 19(3), 421&#x2013;435. 10.1007/s12192-013-0467-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-013-0467-2</ArticleId><ArticleId IdType="pmc">PMC3982033</ArticleId><ArticleId IdType="pubmed">24092395</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, S. , McKinsey, T. A. , Zhang, C. L. , Richardson, J. A. , Hill, J. A. , &amp; Olson, E. N. (2004). Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Molecular and Cellular Biology, 24(19), 8467&#x2013;8476. 10.1128/mcb.24.19.8467-8476.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.24.19.8467-8476.2004</ArticleId><ArticleId IdType="pmc">PMC516756</ArticleId><ArticleId IdType="pubmed">15367668</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, S. , Young, B. D. , Li, S. , Qi, X. , Richardson, J. A. , &amp; Olson, E. N. (2006). Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell, 126(2), 321&#x2013;334. 10.1016/j.cell.2006.05.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.05.040</ArticleId><ArticleId IdType="pubmed">16873063</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, K. , Bennett, S. A. , Rana, N. , Yousuf, H. , Said, M. , Taaseen, S. , &#x2026; Torrente, M. P. (2018). Neurodegenerative disease proteinopathies are connected to distinct histone post&#x2010;translational modification landscapes. ACS Chemical Neuroscience, 9(4), 938&#x2013;948. 10.1021/acschemotorneuroneuro.7b00297</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemotor</ArticleId><ArticleId IdType="pmc">PMC5906139</ArticleId><ArticleId IdType="pubmed">29243911</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, L. F. , &amp; Greene, W. C. (2004). Shaping the nuclear action of NF&#x2010;&#x3ba;B. Nature Reviews Molecular Cell Biology, 5(5), 392&#x2013;401. 10.1038/nrm1368</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm1368</ArticleId><ArticleId IdType="pubmed">15122352</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, S. , Zhang, X. J. , Li, L. X. , Wang, Y. , Zhong, R. J. , &amp; Le, W. (2015). Histone deacetylase 6 delays motor neuron degeneration by ameliorating the autophagic flux defect in a transgenic mouse model of amyotrophic lateral sclerosis. Neuroscience Bulletin, 31(4), 459&#x2013;468. 10.1007/s12264-015-1539-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-015-1539-3</ArticleId><ArticleId IdType="pmc">PMC5563710</ArticleId><ArticleId IdType="pubmed">26164555</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, H. L. , Mostoslavsky, R. , Saito, S. , Manis, J. P. , Gu, Y. , Patel, P. , &#x2026; Chua, K. F. (2003). Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)&#x2010;deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 100(19), 10794&#x2013;10799. 10.1073/pnas.1934713100</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1934713100</ArticleId><ArticleId IdType="pmc">PMC196882</ArticleId><ArticleId IdType="pubmed">12960381</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho, Y. , Sloutsky, R. , Naegle, K. M. , &amp; Cavalli, V. (2013). Injury&#x2010;induced HDAC5 nuclear export is essential for axon regeneration. Cell, 155(4), 894&#x2013;908. 10.1016/j.cell.2013.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.10.004</ArticleId><ArticleId IdType="pmc">PMC3987749</ArticleId><ArticleId IdType="pubmed">24209626</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho, Y. , Park, D. , &amp; Cavalli, V. (2015). Filamin A is required in injured axons for HDAC5 activity and axon regeneration. The Journal of Biological Chemistry, 290(37), 22759&#x2013;22770. 10.1074/jbc.M115.638445</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc</ArticleId><ArticleId IdType="pmc">PMC4566247</ArticleId><ArticleId IdType="pubmed">26157139</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang, D. M. , Leng, Y. , Marinova, Z. , Kim, H. J. , &amp; Chiu, C. T. (2009). Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends in Neurosciences, 32(11), 591&#x2013;601. 10.1016/j.tins.2009.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2009.06.002</ArticleId><ArticleId IdType="pmc">PMC2771446</ArticleId><ArticleId IdType="pubmed">19775759</ArticleId></ArticleIdList></Reference><Reference><Citation>Celen, S. , Rokka, J. , Gilbert, T. M. , Koole, M. , Vermeulen, I. , Serdons, K. , &#x2026; Cawthorne, C. J. (2020). Translation of HDAC6 PET imaging using [18F]EKZ&#x2010;001&#x2013;cGMP production and measurement of HDAC6 target occupancy in nonhuman primates. ACS Chemical Neuroscience, 11(7), 1093&#x2013;1101. 10.1021/acschemotorneuroneuro.0c00074</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemotor</ArticleId><ArticleId IdType="pmc">PMC7205522</ArticleId><ArticleId IdType="pubmed">32159328</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipriani, A. , Reid, K. , Ah, Y. , Macritchie, K. , &amp; Geddes, J. (2013). Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database of Systematic Reviews, 10, 1&#x2013;57. 10.1002/14651858.CD003196.pub2.www.cochranelibrary.com</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003196.pub2.www.cochranelibrary.com</ArticleId><ArticleId IdType="pmc">PMC6599863</ArticleId><ArticleId IdType="pubmed">24132760</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland, D. W. , &amp; Rothstein, J. D. (2001). From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nature Reviews Neuroscience, 2(11), 806&#x2013;819. 10.1038/35097565</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35097565</ArticleId><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen, T. J. , Hwang, A. W. , Restrepo, C. R. , Yuan, C. X. , Trojanowski, J. Q. , &amp; Lee, V. M. Y. (2015). An acetylation switch controls TDP&#x2010;43 function and aggregation propensity. Nature Communications, 6(5845), 1&#x2013;15. 10.1038/ncomms6845</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6845</ArticleId><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita, C. , Zennaro, E. , Fallini, C. , Weber, M. , Sommacal, A. , Buratti, E. , &#x2026; Ratti, A. (2009). TDP&#x2010;43 is recruited to stress granules in conditions of oxidative insult. Journal of Neurochemistry, 111(4), 1051&#x2013;1061. 10.1111/j.1471-4159.2009.06383.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook, C. , Gendron, T. F. , Scheffel, K. , Carlomagno, Y. , Dunmore, J. , DeTure, M. , &amp; Petrucelli, L. (2012). Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation. Human Molecular Genetics, 21(13), 2936&#x2013;2945. 10.1093/hmg/dds125</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds125</ArticleId><ArticleId IdType="pmc">PMC3373241</ArticleId><ArticleId IdType="pubmed">22492994</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcoran, L. J. , Mitchison, T. J. , &amp; Liu, Q. (2004). A novel action of histone deacetylase inhibitors in a protein aggresome disease model. Current Biology, 14, 488&#x2013;492. 10.1016/j.cub.2004.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2004.03.003</ArticleId><ArticleId IdType="pubmed">15043813</ArticleId></ArticleIdList></Reference><Reference><Citation>Corman, A. , Jung, B. , H&#xe4;ggblad, M. , Br&#xe4;utigam, L. , Lafarga, V. , Lidemalm, L. , &#x2026; Fernandez&#x2010;Capetillo, O. (2019). A chemical screen identifies compounds limiting the toxicity of C9ORF72 dipeptide repeats. Cell Chemical Biology, 26(2), 235&#x2013;243.e5. 10.1016/j.chembiol.2018.10.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2018.10.020</ArticleId><ArticleId IdType="pubmed">30527999</ArticleId></ArticleIdList></Reference><Reference><Citation>Crochemore, C. , Virgili, M. , Bonamassa, B. , Canistro, D. , Emiliano, P. A. , Paolini, M. , &amp; Contestabile, A. (2009). Long&#x2010;term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model for amyotrophic lateral sclerosis. Muscle and Nerve, 39(4), 548&#x2013;552. 10.1002/mus.21260</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21260</ArticleId><ArticleId IdType="pubmed">19296491</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz, M. E. , Andres, P. L. , Macdonald, S. A. , Bedlack, R. S. , Choudry, R. , Brown, R. H. , &#x2026; Ferrante, R. J. (2009). Phase 2 study of sodium phenylbutyrate in ALS. Amyotrophic Lateral Sclerosis, 10(2), 99&#x2013;106. 10.1080/17482960802320487</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802320487</ArticleId><ArticleId IdType="pubmed">18688762</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon&#x2010;Nachum, M. , Melamed, E. , &amp; Offen, D. (2011). The &#x201c;dying&#x2010;back&#x201d; phenomenon of motor neurons in ALS. Journal of Molecular Neuroscience, 43(3), 470&#x2013;477. 10.1007/s12031-010-9467-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahiya, S. , Beier, U. H. , Wang, L. , Han, R. , Jiao, J. , Akimova, T. , &#x2026; Hancock, W. W. (2020). HDAC10 deletion promotes Foxp3+ T&#x2010;regulatory cell function. Scientific Reports, 10(1), 1&#x2013;13. 10.1038/s41598-019-57294-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-57294-x</ArticleId><ArticleId IdType="pmc">PMC6965082</ArticleId><ArticleId IdType="pubmed">31949209</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Signore, S. J. , Amante, D. J. , Kim, J. , Stack, E. C. , Goodrich, S. , Cormier, K. , &#x2026; Ferrante, R. J. (2009). Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice. Amyotrophic Lateral Sclerosis, 10(2), 85&#x2013;94. 10.1080/17482960802226148</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802226148</ArticleId><ArticleId IdType="pubmed">18618304</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande, D. , Higelin, J. , Schoen, M. , Vomhof, T. , Boeckers, T. M. , Demestre, M. , &amp; Michaelis, J. (2019). Synaptic FUS localization during motoneuron development and its accumulation in human ALS synapses. Frontiers in Cellular Neuroscience, 13(June), 1&#x2013;17. 10.3389/fncel.2019.00256</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00256</ArticleId><ArticleId IdType="pmc">PMC6582137</ArticleId><ArticleId IdType="pubmed">31244613</ArticleId></ArticleIdList></Reference><Reference><Citation>Dios, A. M. , Babu, S. , Granucci, E. J. , Mueller, K. A. , Mills, A. N. , Alshikho, M. J. , &#x2026; Sadri&#x2010;Vakili, G. (2019). Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidence. Muscle and Nerve, 60(4), 443&#x2013;452. 10.1002/mus.26620</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26620</ArticleId><ArticleId IdType="pubmed">31241177</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobbin, M. M. , Madabhushi, R. , Pan, L. , Chen, Y. , Kim, D. , Gao, J. , &#x2026; Tsai, L. H. (2013). SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons. Nature Neuroscience, 16(8), 1008&#x2013;1015. 10.1038/nn.3460</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3460</ArticleId><ArticleId IdType="pmc">PMC4758134</ArticleId><ArticleId IdType="pubmed">23852118</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis, L. , Gonzalez de Aguilar, J. L. , Echaniz&#x2010;Laguna, A. , Eschbach, J. , Rene, F. , Oudart, H. , &#x2026; Loeffler, J. P. (2009). Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS ONE, 4(4), 1&#x2013;12, e5390. 10.1371/journal.pone.0005390</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005390</ArticleId><ArticleId IdType="pmc">PMC2671839</ArticleId><ArticleId IdType="pubmed">19404401</ArticleId></ArticleIdList></Reference><Reference><Citation>Echaniz&#x2010;Laguna, A. , Bousiges, O. , Loeffler, J.&#x2010;P. , &amp; Boutillier, A.&#x2010;L. (2008). Histone deacetylase inhibitors: Therapeutic agents and research tools for deciphering motor neuron diseases. Current Medicinal Chemistry, 15(13), 1263&#x2013;1273. 10.2174/092986708784534974</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986708784534974</ArticleId><ArticleId IdType="pubmed">18537606</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia, A. E. , Lalli, S. , Monsurr&#xf2;, M. R. , Sagnelli, A. , Taiello, A. C. , Reggiori, B. , &#x2026; Albanese, A. (2016). Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. European Journal of Neurology, 23(1), 45&#x2013;52. 10.1111/ene.12664</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12664</ArticleId><ArticleId IdType="pmc">PMC5024041</ArticleId><ArticleId IdType="pubmed">25664595</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng, H. L. , Leng, Y. , Ma, C. H. , Zhang, J. , Ren, M. , &amp; Chuang, D. M. (2008). Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience, 155(3), 567&#x2013;572. 10.1016/j.neuroscience.2008.06.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2008.06.040</ArticleId><ArticleId IdType="pmc">PMC2709275</ArticleId><ArticleId IdType="pubmed">18640245</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa&#x2010;Romero, C. , Hur, J. , Bender, D. E. , Delaney, C. E. , Cataldo, M. D. , Smith, A. L. , &#x2026; Feldman, E. L. (2012). Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS ONE, 7(12), 1&#x2013;15, e52672. 10.1371/journal.pone.0052672</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052672</ArticleId><ArticleId IdType="pmc">PMC3530456</ArticleId><ArticleId IdType="pubmed">23300739</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa&#x2010;Romero, C. , Hur, J. , Lunna, J. S. , Paez&#x2010;Colasantea, X. , Bendera, D. E. , Yung, R. , &#x2026; Feldman, E. L. (2016). Expression of microRNAs in human post&#x2010;mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Molecular and Cellular Neurosciences, 71, 34&#x2013;45. 10.1016/j.mcn.2015.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.12.008</ArticleId><ArticleId IdType="pmc">PMC4761498</ArticleId><ArticleId IdType="pubmed">26704906</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer, L. R. , Culver, D. G. , Tennant, P. , Davis, A. A. , Wang, M. , Castellano&#x2010;Sanchez, A. , &#x2026; Glass, J. D. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Experimental Neurology, 185(2), 232&#x2013;240. 10.1016/j.expneurol.2003.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischle, W. , Dequiedt, F. , Hendzel, M. J. , Guenther, M. G. , Lazar, M. A. , Voelter, W. , &amp; Verdin, E. (2002). Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N&#x2010;CoR. Molecular Cell, 9(1), 45&#x2013;57. 10.1016/S1097-2765(01)00429-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(01)00429-4</ArticleId><ArticleId IdType="pubmed">11804585</ArticleId></ArticleIdList></Reference><Reference><Citation>Fourcade, S. , Morat&#xf3;, L. , Parameswaran, J. , Ruiz, M. , Ruiz&#x2010;Cort&#xe9;s, T. , Jov&#xe9;, M. , &#x2026; Pujol, A. (2017). Loss of SIRT2 leads to axonal degeneration and locomotor disability associated with redox and energy imbalance. Aging Cell, 16(6), 1404&#x2013;1413. 10.1111/acel.12682</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12682</ArticleId><ArticleId IdType="pmc">PMC5676070</ArticleId><ArticleId IdType="pubmed">28984064</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal, J. , Chen, J. , Barnett, K. R. , Yang, L. , Brumley, E. , &amp; Zhu, H. (2013). HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation. Journal of Biological Chemistry, 288(21), 15035&#x2013;15045. 10.1074/jbc.M112.431957</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.431957</ArticleId><ArticleId IdType="pmc">PMC3663524</ArticleId><ArticleId IdType="pubmed">23580651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan, L. , &amp; Mucke, L. (2008). Paths of convergence: Sirtuins in aging and neurodegeneration. Neuron, 58(1), 10&#x2013;14. 10.1016/j.neuron.2008.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.03.015</ArticleId><ArticleId IdType="pmc">PMC8245119</ArticleId><ArticleId IdType="pubmed">18400158</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert, T. M. , Z&#xfc;rcher, N. R. , Catanese, M. C. , Tseng, C. E. , Di Biase, M. A. , Lyall, A. E. , &#x2026; Hibert, M. L. (2019). Neuroepigenetic signatures of age and sex in the living human brain. Nature Communications, 10(1), 1&#x2013;9. 10.1038/s41467-019-11031-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11031-0</ArticleId><ArticleId IdType="pmc">PMC6610136</ArticleId><ArticleId IdType="pubmed">31270332</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong, J. , Huang, M. , Wang, F. , Ma, X. , Liu, H. , Tu, Y. , &#x2026; Tang, T. S. (2017). RBM45 competes with HDAC1 for binding to FUS in response to DNA damage. Nucleic Acids Research, 45(22), 12862&#x2013;12876. 10.1093/nar/gkx1102</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1102</ArticleId><ArticleId IdType="pmc">PMC5728411</ArticleId><ArticleId IdType="pubmed">29140459</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, W. , Naujock, M. , Fumagalli, L. , Vandoorne, T. , Baatsen, P. , Boon, R. , &#x2026; Van Den Bosch, L. (2017). HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS&#x2010;ALS patients. Nature Communications, 8(1), 1&#x2013;14. 10.1038/s41467-017-00911-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00911-y</ArticleId><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberland, M. , Mokalled, M. H. , Montgomery, R. L. , &amp; Olson, E. N. (2009). Epigenetic control of skull morphogenesis by histone deacetylase 8. Genes and Development, 23(14), 1625&#x2013;1630. 10.1101/gad.1809209</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1809209</ArticleId><ArticleId IdType="pmc">PMC2714711</ArticleId><ArticleId IdType="pubmed">19605684</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, Q. , Lu, J. , Duan, J. , Su, D. , Hou, X. , Li, F. , &#x2026; Huang, B. (2008). Gcn5&#x2010; and Elp3&#x2010;induced histone H3 acetylation regulates hsp70 gene transcription in yeast. Biochemical Journal, 409(3), 779&#x2013;788. 10.1042/bj20070578</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj20070578</ArticleId><ArticleId IdType="pubmed">17910533</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo, K. , Lim, S. M. , Nahm, M. , Kim, Y. E. , Oh, K. W. , Park, H. T. , &#x2026; Lee, S. (2018). A de novo RAPGEF2 variant identified in a sporadic amyotrophic lateral sclerosis patient impairs microtubule stability and axonal mitochondria distribution. Experimental Neurobiology, 27(6), 550&#x2013;563. 10.5607/en.2018.27.6.550</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2018.27.6.550</ArticleId><ArticleId IdType="pmc">PMC6318558</ArticleId><ArticleId IdType="pubmed">30636905</ArticleId></ArticleIdList></Reference><Reference><Citation>Herskovits, A. Z. , Hunter, T. A. , Maxwell, N. , Pereira, K. , Whittaker, C. A. , Valdez, G. , &amp; Guarente, L. P. (2018). SIRT1 deacetylase in aging&#x2010;induced neuromuscular degeneration and amyotrophic lateral sclerosis. Aging Cell, 17(6), 1&#x2013;11. 10.1111/acel.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12839</ArticleId><ArticleId IdType="pmc">PMC6260920</ArticleId><ArticleId IdType="pubmed">30295421</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbert, C. , Guardiola, A. , Shao, R. , Kawaguchi, Y. , Ito, A. , Nixon, A. , &#x2026; Yao, T. P. (2002). HDAC6 is a microtubule&#x2010;associated deacetylase. Nature, 417(6887), 455&#x2013;458. 10.1038/417455a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/417455a</ArticleId><ArticleId IdType="pubmed">12024216</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob, C. , Christen, C. N. , Pereira, J. A. , Somandin, C. , Baggiolini, A. , L&#xf6;tscher, P. , &#x2026; Suter, U. (2011). HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells. Nature Neuroscience, 14(4), 429&#x2013;436. 10.1038/nn.2762</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2762</ArticleId><ArticleId IdType="pubmed">21423190</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen, C. , Schmalbach, S. , Boeselt, S. , Sarlette, A. , Dengler, R. , &amp; Petri, S. (2010). Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis. Journal of Neuropathology and Experimental Neurology, 69(6), 573&#x2013;581. 10.1097/NEN.0b013e3181ddd404</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181ddd404</ArticleId><ArticleId IdType="pubmed">20467334</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia, H. , Pallos, J. , Jacques, V. , Lau, A. , Tang, B. , Cooper, A. , &#x2026; Leslie, M. (2012). Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine&#x2010;elicited phenotypes in systems of Huntington's disease. Neurobiology of Disease, 46(2), 351&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3528106</ArticleId><ArticleId IdType="pubmed">22590724</ArticleId></ArticleIdList></Reference><Reference><Citation>Jochems, J. , Boulden, J. , Lee, B. G. , Blendy, J. A. , Jarpe, M. , Mazitschek, R. , &#x2026; Berton, O. (2014). Antidepressant&#x2010;like properties of novel HDAC6&#x2010;selective inhibitors with improved brain bioavailability. Neuropsychopharmacology, 39(2), 389&#x2013;400. 10.1038/npp.2013.207</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2013.207</ArticleId><ArticleId IdType="pmc">PMC3870780</ArticleId><ArticleId IdType="pubmed">23954848</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi, P. , Greco, T. M. , Guise, A. J. , Luo, Y. , Yu, F. , Nesvizhskii, A. I. , &amp; Cristea, I. M. (2013). The functional interactome landscape of the human histone deacetylase family. Molecular Systems Biology, 9(1), 1&#x2013;21. 10.1038/msb.2013.26</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/msb.2013.26</ArticleId><ArticleId IdType="pmc">PMC3964310</ArticleId><ArticleId IdType="pubmed">23752268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalinski, A. L. , Kar, A. N. , Craver, J. , Tosolini, A. P. , Sleigh, J. N. , Lee, S. J. , &#x2026; Twiss, J. L. (2019). Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition. Journal of Cell Biology, 218(6), 1871&#x2013;1890. 10.1083/jcb.201702187</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201702187</ArticleId><ArticleId IdType="pmc">PMC6548128</ArticleId><ArticleId IdType="pubmed">31068376</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassis, H. , Shehadah, A. , Chopp, M. , Roberts, C. , &amp; Zhang, Z. G. (2015). Stroke Induces Nuclear Shuttling of Histone Deacetylase 4. Stroke, 46(7), 1909&#x2013;1915. 10.1161/strokeaha.115.009046</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.115.009046</ArticleId><ArticleId IdType="pmc">PMC4480163</ArticleId><ArticleId IdType="pubmed">25967576</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama, S. , Morii, A. , Makanga, J. O. , Suzuki, T. , Miyata, N. , &amp; Inazu, T. (2018). HDAC8 regulates neural differentiation through embryoid body formation in P19 cells. Biochemical and Biophysical Research Communications, 498(1), 45&#x2013;51. 10.1016/j.bbrc.2018.02.195</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.02.195</ArticleId><ArticleId IdType="pubmed">29499194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, D. , Frank, C. L. , Dobbin, M. M. , Tsunemoto, R. K. , Tu, W. , Peng, P. L. , &#x2026; Tsai, L. H. (2008). Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron, 60(5), 803&#x2013;817. 10.1016/j.neuron.2008.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.10.015</ArticleId><ArticleId IdType="pmc">PMC2912147</ArticleId><ArticleId IdType="pubmed">19081376</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, S. H. , Shanware, N. P. , Bowler, M. J. , &amp; Tibbetts, R. S. (2010). Amyotrophic lateral sclerosis&#x2010;associated proteins TDP&#x2010;43 and FUS/TLS function in a common biochemical complex to co&#x2010;regulate HDAC6 mRNA. Journal of Biological Chemistry, 285(44), 34097&#x2013;34105. 10.1074/jbc.M110.154831</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.154831</ArticleId><ArticleId IdType="pmc">PMC2962508</ArticleId><ArticleId IdType="pubmed">20720006</ArticleId></ArticleIdList></Reference><Reference><Citation>Koole, M. , Van Weehaeghe, D. , Serdons, K. , Herbots, M. , Cawthorne, C. , Celen, S. , &#x2026; Gilbert, T. M. (2020). Clinical validation of the novel HDAC6 radiotracer [18F]EKZ&#x2010;001 in the human brain. European Journal of Nuclear Medicine and Molecular Imaging. 10.1007/s00259-020-04891-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04891-y</ArticleId><ArticleId IdType="pmc">PMC7835181</ArticleId><ArticleId IdType="pubmed">32638097</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;rner, S. , B&#xf6;selt, S. , Thau, N. , Rath, K. J. , Dengler, R. , &amp; Petri, S. (2013). Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: Neuroprotective or neurotoxic properties of sirtuins in ALS? Neurodegenerative Diseases, 11(3), 141&#x2013;152. 10.1159/000338048</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000338048</ArticleId><ArticleId IdType="pubmed">22796962</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs, J. J. , Yao, T.&#x2010;P. , Kawaguchi, Y. , Mclaurin, A. , Vance, J. M. , Ito, A. , &amp; Yao, T.&#x2010;P. (2003). The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell, 115, 727&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pubmed">14675537</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuta, R. , Larochelle, N. , Fernandez, M. , Pal, A. , Minotti, S. , Tibshirani, M. , &#x2026; Durham, H. D. (2020). Depending on the stress, histone deacetylase inhibitors act as heat shock protein co&#x2010;inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS models. Cell Stress &amp; Chaperones, 25(1), 173&#x2013;191. 10.1007/s12192-019-01064-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-019-01064-1</ArticleId><ArticleId IdType="pmc">PMC6985055</ArticleId><ArticleId IdType="pubmed">31900865</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon, S. , Zhang, Y. , &amp; Matthias, P. (2007). The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response. Genes &amp; Development, 21(24), 3381&#x2013;3394. 10.1101/gad.461107.lates</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.461107.lates</ArticleId><ArticleId IdType="pmc">PMC2113037</ArticleId><ArticleId IdType="pubmed">18079183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomblez, L. , Bensimon, G. , Meininger, V. , Leigh, P. N. , &amp; Guillet, P. (1996). Dose&#x2010;ranging study of riluzole in amyotrophic lateral sclerosis. The Lancet, 347(9013), 1425&#x2013;1431. 10.5555/uri:pii:S0140673696916803</Citation><ArticleIdList><ArticleId IdType="doi">10.5555/uri:pii:S0140673696916803</ArticleId><ArticleId IdType="pubmed">8676624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagger, G. , O'Carroll, D. , Rembold, M. , Khier, H. , Tischler, J. , Weitzer, G. , &#x2026; Seiser, C. (2002). Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO Journal, 21(11), 2672&#x2013;2681. 10.1093/emboj/21.11.2672</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/21.11.2672</ArticleId><ArticleId IdType="pmc">PMC126040</ArticleId><ArticleId IdType="pubmed">12032080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanka, V. , Wieland, S. , Barber, J. , &amp; Cudkowicz, M. (2009). Arimoclomol: A potential therapy under development for ALS. Expert Opinion on Investigational Drugs, 18(12), 1907&#x2013;1918. 10.1517/13543780903357486</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/13543780903357486</ArticleId><ArticleId IdType="pubmed">19938902</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapucci, A. , Cavone, L. , Buonvicino, D. , Felici, R. , Gerace, E. , Zwergel, C. , &#x2026; Chiarugi, A. (2017). Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1&#x2010;ALS mice. Neuroscience Letters, 656, 120&#x2013;125. 10.1016/j.neulet.2017.07.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.07.033</ArticleId><ArticleId IdType="pubmed">28732762</ArticleId></ArticleIdList></Reference><Reference><Citation>Laws, M. T. , Bonomi, R. E. , Kamal, S. , Gelovani, D. J. , Llaniguez, J. , Potukutchi, S. , &#x2026; Gelovani, J. G. (2019). Molecular imaging HDACs class IIa expression&#x2010;activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [18F]TFAHA. Scientific Reports, 9(1), 1&#x2013;11. 10.1038/s41598-019-40054-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-40054-2</ArticleId><ArticleId IdType="pmc">PMC6401080</ArticleId><ArticleId IdType="pubmed">30837601</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J. C. , Shin, J. H. , Park, B. W. , Kim, G. S. , Kim, J. C. , Kang, K. S. , &amp; Cha, C. I. (2012). Region&#x2010;specific changes in the immunoreactivity of SIRT1 expression in the central nervous system of SOD1G93A transgenic mice as an in vivo model of amyotrophic lateral sclerosis. Brain Research, 1433, 20&#x2013;28. 10.1016/j.brainres.2011.11.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.11.019</ArticleId><ArticleId IdType="pubmed">22137654</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J. Y. , Nagano, Y. , Taylor, J. P. , Lim, K. L. , &amp; Yao, T. P. (2010). Disease&#x2010;causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6&#x2010;dependent mitophagy. Journal of Cell Biology, 189(4), 671&#x2013;679. 10.1083/jcb.201001039</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201001039</ArticleId><ArticleId IdType="pmc">PMC2872903</ArticleId><ArticleId IdType="pubmed">20457763</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, J. , Chen, J. , Ricupero, C. L. , Hart, R. P. , Schwartz, M. S. , Kusnecov, A. , &amp; Herrup, K. (2012). Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nature Medicine, 18(5), 783&#x2013;790. 10.1038/nm.2709</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2709</ArticleId><ArticleId IdType="pmc">PMC3378917</ArticleId><ArticleId IdType="pubmed">22466704</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y. , Zhang, X. , Polakiewicz, R. D. , &amp; Yao, T. (2008). HDAC6 is required for epidermal growth factor&#x2010;induced &#x3b2;&#x2010;catenin nuclear localization. The Journal of Biological Chemistry, 283(19), 12686&#x2013;12690. 10.1074/jbc.C700185200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C700185200</ArticleId><ArticleId IdType="pmc">PMC3762558</ArticleId><ArticleId IdType="pubmed">18356165</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, J. , Song, M. , Moh, S. , Kim, H. , &amp; Kim, D.&#x2010;H. (2019). Cytoplasmic restriction of mutated SOD1 impairs the DNA repair process in spinal cord neurons. Cell, 8(12), 1502&#x2010;1&#x2013;20. 10.3390/cells8121502</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8121502</ArticleId><ArticleId IdType="pmc">PMC6952796</ArticleId><ArticleId IdType="pubmed">31771229</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, D. , Liu, C. , Li, J. , Azadzoi, K. , Yang, Y. , Fei, Z. , &#x2026; Yang, J. H. (2013). Proteomic analysis reveals differentially regulated protein acetylation in human amyotrophic lateral sclerosis spinal cord. PLoS ONE, 8(12), 1&#x2013;11, e80779. 10.1371/journal.pone.0080779</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080779</ArticleId><ArticleId IdType="pmc">PMC3846615</ArticleId><ArticleId IdType="pubmed">24312501</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler, J. P. , Picchiarelli, G. , Dupuis, L. , &amp; Gonzalez De Aguilar, J. L. (2016). The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathology, 26(2), 227&#x2013;236. 10.1111/bpa.12350</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12350</ArticleId><ArticleId IdType="pmc">PMC8029271</ArticleId><ArticleId IdType="pubmed">26780251</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, S. , Zhang, Y. , Kalin, J. H. , Cai, L. , Kozikowski, A. P. , &amp; Pike, V. W. (2016). Exploration of the labeling of [11C]tubastatin A at the hydroxamic acid site with [11C]carbon monoxide. Journal of Labelled Compounds and Radiopharmaceuticals, 59(1), 9&#x2013;13. 10.1002/jlcr.3360</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlcr.3360</ArticleId><ArticleId IdType="pmc">PMC4715750</ArticleId><ArticleId IdType="pubmed">26647018</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, C. , &amp; D'Mello, S. R. (2011). Neuroprotection by histone deacetylase&#x2010;7 (HDAC7) occurs by inhibition of c&#x2010;jun expression through a deacetylase&#x2010;independent mechanism. Journal of Biological Chemistry, 286(6), 4819&#x2013;4828. 10.1074/jbc.M110.146860</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.146860</ArticleId><ArticleId IdType="pmc">PMC3039335</ArticleId><ArticleId IdType="pubmed">21118817</ArticleId></ArticleIdList></Reference><Reference><Citation>Mai, A. , Massa, S. , Pezzi, R. , Simeoni, S. , Rotili, D. , Nebbioso, A. , &#x2026; Brosch, G. (2005). Class II (IIa)&#x2010;selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. Journal of Medicinal Chemistry, 48(9), 3344&#x2013;3353. 10.1021/jm049002a</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm049002a</ArticleId><ArticleId IdType="pubmed">15857140</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso, R. , del Valle, J. , Modol, L. , Martinez, A. , Granado&#x2010;Serrano, A. B. , Ramirez&#x2010;N&#xfa;&#xf1;ez, O. , &#x2026; Navarro, X. (2014). Resveratrol improves motoneuron function and extends survival in SOD1G93A ALS mice. Neurotherapeutics, 11(2), 419&#x2013;432. 10.1007/s13311-013-0253-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-013-0253-y</ArticleId><ArticleId IdType="pmc">PMC3996124</ArticleId><ArticleId IdType="pubmed">24414863</ArticleId></ArticleIdList></Reference><Reference><Citation>Markert, C. D. , Kim, E. , Gifondorwa, D. J. , Childers, M. K. , &amp; Milligan, C. E. (2010). A single&#x2010;dose resveratrol treatment in a mouse model of amyotrophic lateral sclerosis. Journal of Medicinal Food, 13(5), 1081&#x2013;1085. 10.1089/jmf.2009.0243</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2009.0243</ArticleId><ArticleId IdType="pubmed">20626250</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinsey, T. A. , Zhang, C. L. , Lu, J. , &amp; Olson, E. N. (2000). Signal&#x2010;dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature, 408(6808), 106&#x2013;111. 10.1038/35040593</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35040593</ArticleId><ArticleId IdType="pmc">PMC4459600</ArticleId><ArticleId IdType="pubmed">11081517</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell, J. C. , McGoldrick, P. , Vance, C. , Hortobagyi, T. , Sreedharan, J. , Rogelj, B. , &#x2026; Shaw, C. E. (2013). Overexpression of human wild&#x2010;type FUS causes progressive motor neuron degeneration in an age&#x2010; and dose&#x2010;dependent fashion. Acta Neuropathologica, 125(2), 273&#x2013;288. 10.1007/s00401-012-1043-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery, R. L. , Davis, C. A. , Potthoff, M. J. , Haberland, M. , Fielitz, J. , Qi, X. , &#x2026; Olson, E. N. (2007). Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes and Development, 21(14), 1790&#x2013;1802. 10.1101/gad.1563807</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1563807</ArticleId><ArticleId IdType="pmc">PMC1920173</ArticleId><ArticleId IdType="pubmed">17639084</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery, R. L. , Potthoff, M. J. , Haberland, M. , Qi, X. , Matsuzaki, S. , Humphries, K. M. , &#x2026; Olson, E. N. (2008). Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. Journal of Clinical Investigation, 118(11), 3588&#x2013;3597. 10.1172/JCI35847</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI35847</ArticleId><ArticleId IdType="pmc">PMC2556240</ArticleId><ArticleId IdType="pubmed">18830415</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori, K. , Weng, S.&#x2010;M. , Arzberger, T. , May, S. , Rentzsch, K. , Kremmer, E. , &#x2026; Edbauer, D. (2013). The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide&#x2010;Repeat Proteins in FTLD/ALS. Science, 339(6125), 1335&#x2013;1338. 10.1126/science.1232927</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison, B. E. , Majdzadeh, N. , Zhang, X. , Lyles, A. , Bassel&#x2010;Duby, R. , Olson, E. N. , &amp; D'Mello, S. R. (2006). Neuroprotection by histone deacetylase&#x2010;related protein. Molecular and Cellular Biology, 26(9), 3550&#x2013;3564. 10.1128/mcb.26.9.3550-3564.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.26.9.3550-3564.2006</ArticleId><ArticleId IdType="pmc">PMC1447420</ArticleId><ArticleId IdType="pubmed">16611996</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy, S. P. , Lee, R. J. , McClean, M. E. , Pemberton, H. E. , Uo, T. , Morrison, R. S. , &#x2026; Baltan, S. (2014). MS&#x2010;275, a Class I histone deacetylase inhibitor, protects the p53&#x2010;deficient mouse against ischemic injury. Journal of Neurochemistry, 129(3), 509&#x2013;515. 10.1111/jnc.12498</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12498</ArticleId><ArticleId IdType="pmc">PMC8937574</ArticleId><ArticleId IdType="pubmed">24147654</ArticleId></ArticleIdList></Reference><Reference><Citation>Naga&#x144;ska, E. , Matyja, E. , Taraszewska, A. , &amp; Rafa&#x142;owska, J. (2015). Protective effect of valproic acid on cultured motor neurons under glutamate excitotoxic conditions. Ultrastructural study. Folia Neuropathologica, 53(4), 309&#x2013;316. 10.5114/fn.2015.56545</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/fn.2015.56545</ArticleId><ArticleId IdType="pubmed">26785365</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey, U. B. , Nie, Z. , Batlevi, Y. , McCray, B. A. , Ritson, G. P. , Nedelsky, N. B. , &#x2026; Taylor, J. P. (2007). HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature, 447(7146), 859&#x2013;863. 10.1038/nature05853</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05853</ArticleId><ArticleId IdType="pubmed">17568747</ArticleId></ArticleIdList></Reference><Reference><Citation>Parmigiani, R. B. , Xu, W. S. , Venta&#x2010;Perez, G. , Erdjument&#x2010;Bromage, H. , Yaneva, M. , Tempst, P. , &amp; Marks, P. A. (2008). HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation. Proceedings of the National Academy of Sciences of the United States of America, 105(28), 9633&#x2013;9638. 10.1073/pnas.0803749105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0803749105</ArticleId><ArticleId IdType="pmc">PMC2443817</ArticleId><ArticleId IdType="pubmed">18606987</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri, S. , Kiaei, M. , Kipiani, K. , Chen, J. , Calingasan, N. Y. , Crow, J. P. , &amp; Beal, M. F. (2006). Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease, 22(1), 40&#x2013;49. 10.1016/j.nbd.2005.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.09.013</ArticleId><ArticleId IdType="pubmed">16289867</ArticleId></ArticleIdList></Reference><Reference><Citation>Piepers, S. , Veldink, J. H. , De Jong, S. W. , Van Der Tweel, I. , Van Der Pol, W. L. , Uijtendaal, E. V. , &#x2026; Van Den Berg, L. H. (2009). Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis. Annals of Neurology, 66(2), 227&#x2013;234. 10.1002/ana.21620</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21620</ArticleId><ArticleId IdType="pubmed">19743466</ArticleId></ArticleIdList></Reference><Reference><Citation>Pigna, E. , Simonazzi, E. , Sanna, K. , Bernadzki, K. M. , Proszynski, T. , Heil, C. , &#x2026; Moresi, V. (2019). Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis. eBioMedicine, 40, 717&#x2013;732. 10.1016/j.ebiom.2019.01.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.01.038</ArticleId><ArticleId IdType="pmc">PMC6414308</ArticleId><ArticleId IdType="pubmed">30713114</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu, H. , Lee, S. , Shang, Y. , Wang, W. Y. , Au, K. F. , Kamiya, S. , &#x2026; Huang, E. J. (2014). ALS&#x2010;associated mutation FUS&#x2010;R521C causes DNA damage and RNA splicing defects. Journal of Clinical Investigation, 124(3), 981&#x2013;999. 10.1172/JCI72723</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI72723</ArticleId><ArticleId IdType="pmc">PMC3938263</ArticleId><ArticleId IdType="pubmed">24509083</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton, A. E. , Chi&#xf2;, A. , &amp; Traynor, B. J. (2014). State of play in amyotrophic lateral sclerosis genetics. Nature Neuroscience, 17(1), 17&#x2013;23. 10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva, N. , Clarelli, F. , Domi, T. , Cerri, F. , Gallia, F. , Trimarco, A. , &#x2026; Quattrini, A. (2016). Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: Insights into pathogenesis. Scientific Reports, 6, 1&#x2013;15. 10.1038/srep39297</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep39297</ArticleId><ArticleId IdType="pmc">PMC5159906</ArticleId><ArticleId IdType="pubmed">27982123</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen, D. R. , Siddiquet, T. , Pattersont, D. , Figlewicz, D. A. , Ii, P. S. , Hentatit, A. , &#x2026; Jr, R. H. B. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59&#x2013;62. 10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossaert, E. , Pollari, E. , Jaspers, T. , Van Helleputte, L. , Jarpe, M. , Van Damme, P. , &#x2026; Van Den Bosch, L. (2019). Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathologica Communications, 7(1), 107&#x2010;1&#x2013;19. 10.1186/s40478-019-0750-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0750-2</ArticleId><ArticleId IdType="pmc">PMC6612190</ArticleId><ArticleId IdType="pubmed">31277703</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouaux, C. , Jokic, N. , Mbebi, C. , Boutillier, S. , Loeffler, J. P. , &amp; Boutillier, A. L. (2003). Critical loss of CBP/p300 histone acetylase activity by caspase&#x2010;6 during neurodegeneration. EMBO Journal, 22(24), 6537&#x2013;6549. 10.1093/emboj/cdg615</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/cdg615</ArticleId><ArticleId IdType="pmc">PMC291810</ArticleId><ArticleId IdType="pubmed">14657026</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouaux, C. , Panteleeva, I. , Ren&#xe9;, F. , De Aguilar, J. L. G. , Echaniz&#x2010;Laguna, A. , Dupuis, L. , &#x2026; Loeffler, J. P. (2007). Sodium valproate exerts neuroprotective effects in vivo through CREB&#x2010;binding protein&#x2010;dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. Journal of Neuroscience, 27(21), 5535&#x2013;5545. 10.1523/JNEUROSCI.1139-07.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1139-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672753</ArticleId><ArticleId IdType="pubmed">17522299</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu, H. , Smith, K. , Camelo, S. I. , Carreras, I. , Lee, J. , Iglesias, A. H. , &#x2026; Ferrante, R. J. (2005). Sodium phenylbutyrate prolongs survival and regulates expression of anti&#x2010;apoptotic genes in transgenic amyotrophic lateral sclerosis mice. Journal of Neurochemistry, 93(5), 1087&#x2013;1098. 10.1111/j.1471-4159.2005.03077.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03077.x</ArticleId><ArticleId IdType="pubmed">15934930</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito, A. , Yamashita, T. , Mariko, Y. , Nosaka, Y. , Tsuchiya, K. , Ando, T. , &#x2026; Nakanishi, O. (1999). A synthetic inhibitor of histone deacetylase, MS&#x2010;27&#x2010;275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. USA, 96(April), 4592&#x2013;4597. 10.1073/pnas.96.8.4592</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.8.4592</ArticleId><ArticleId IdType="pmc">PMC16377</ArticleId><ArticleId IdType="pubmed">10200307</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito, M. , Hess, D. , Eglinger, J. , Fritsch, A. W. , Kreysing, M. , Weinert, B. T. , &#x2026; Matthias, P. (2019). Acetylation of intrinsically disordered regions regulates phase separation. Nature Chemical Biology, 15(1), 51&#x2013;61. 10.1038/s41589-018-0180-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41589-018-0180-7</ArticleId><ArticleId IdType="pubmed">30531905</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna, S. , Esposito, S. , Masala, A. , Sini, P. , Nieddu, G. , Galioto, M. , &#x2026; Crosio, C. (2020). HDAC1 inhibition ameliorates TDP&#x2010;43&#x2010;induced cell death in vitro and in vivo. Cell Death &amp; Disease, 11, 369&#x2010;1&#x2013;14. 10.1038/s41419-020-2580-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2580-3</ArticleId><ArticleId IdType="pmc">PMC7224392</ArticleId><ArticleId IdType="pubmed">32409664</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic&#x2010;Zahirovic, J. , Sendscheid, O. , El Oussini, H. , Jambeau, M. , Sun, Y. , Mersmann, S. , &#x2026; Dupuis, L. (2016). Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. The EMBO Journal, 35(10), 1077&#x2013;1097. 10.15252/embj.201592559</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592559</ArticleId><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino, L. , Bonafede, R. , Scambi, I. , Parrella, E. , Pizzi, M. , &amp; Mariotti, R. (2018). Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model. Scientific Reports, 8(1), 1&#x2013;13. 10.1038/s41598-018-30659-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-30659-4</ArticleId><ArticleId IdType="pmc">PMC6110772</ArticleId><ArticleId IdType="pubmed">30150770</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen, S. , &amp; Kozikowski, A. P. (2020). A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014&#x2013;2019). Expert Opinion on Therapeutic Patents, 30(2), 121&#x2013;136. 10.1080/13543776.2019.1708901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543776.2019.1708901</ArticleId><ArticleId IdType="pmc">PMC6950832</ArticleId><ArticleId IdType="pubmed">31865813</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson, C. L. , Lemmens, R. , Miskiewicz, K. , Broom, W. J. , Hansen V. K., van Vught, P. W. J. , &#x2026; Al&#x2010;Chalabi, A. (2009). Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Human Molecular Genetics, 18(3), 472&#x2013;481. 10.1093/hmg/ddn375</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn375</ArticleId><ArticleId IdType="pmc">PMC2638803</ArticleId><ArticleId IdType="pubmed">18996918</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, W. , Song, Y. , Kincaid, B. , Bossy, B. , &amp; Bossy&#x2010;Wetzel, E. (2013). Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: Neuroprotection by SIRT3 and PGC&#x2010;1&#x3b1;. Neurobiology of Disease, 51, 72&#x2013;81. 10.1016/j.nbd.2012.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.07.004</ArticleId><ArticleId IdType="pmc">PMC3992938</ArticleId><ArticleId IdType="pubmed">22819776</ArticleId></ArticleIdList></Reference><Reference><Citation>Strebl, M. G. , Campbell, A. J. , Zhao, W. N. , Schroeder, F. A. , Riley, M. M. , Chindavong, P. S. , &#x2026; Hooker, J. M. (2017). HDAC6 brain mapping with [18F]Bavarostat enabled by a Ru&#x2010;mediated deoxyfluorination. ACS Central Science, 3(9), 1006&#x2013;1014. 10.1021/acscentsci.7b00274</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.7b00274</ArticleId><ArticleId IdType="pmc">PMC5620987</ArticleId><ArticleId IdType="pubmed">28979942</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugai, F. , Yamamoto, Y. , Miyaguchi, K. , Zhou, Z. , Sumi, H. , Hamasaki, T. , &#x2026; Sakoda, S. (2004). Benefit of valproic acid in suppressing disease progression of ALS model mice. European Journal of Neuroscience, 20(11), 3179&#x2013;3183. 10.1111/j.1460-9568.2004.03765.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2004.03765.x</ArticleId><ArticleId IdType="pubmed">15579172</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, L. , Marin de Evsikova, C. , Bian, K. , Achille, A. , Telles, E. , Pei, H. , &amp; Seto, E. (2018). Programming and regulation of metabolic homeostasis by HDAC11. eBioMedicine, 33, 157&#x2013;168. 10.1016/j.ebiom.2018.06.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.06.025</ArticleId><ArticleId IdType="pmc">PMC6085537</ArticleId><ArticleId IdType="pubmed">29958910</ArticleId></ArticleIdList></Reference><Reference><Citation>

Swinnen, B.
, 
Koen Van Laere, K.
, &amp; 
Van Damme, P.
 (2016). PET imaging in ALS. In Sibat H. F. &amp; de Fatima Iba&#xf1;ez Vald&#xe9;s L. (Eds.), Update on amyotrophic lateral sclerosis. IntechOpen. 10.5772/63545. Available from:, https://www.intechopen.com/books/update-on-amyotrophic-lateral-sclerosis/pet-imaging-in-als
</Citation><ArticleIdList><ArticleId IdType="doi">10.5772/63545</ArticleId></ArticleIdList></Reference><Reference><Citation>Taes, I. , Timmers, M. , Hersmus, N. , Bento&#x2010;Abreu, A. , Van Den Bosch, L. , Van Damme, P. , &#x2026; Robberecht, W. (2013). Hdac6 deletion delays disease progression in the SOD1 G93A mouse model of ALS. Human Molecular Genetics, 22(9), 1783&#x2013;1790. 10.1093/hmg/ddt028</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt028</ArticleId><ArticleId IdType="pubmed">23364049</ArticleId></ArticleIdList></Reference><Reference><Citation>Tago, T. , Toyohara, J. , &amp; Ishii, K. (2020). Radiosynthesis and preliminary evaluation of an 18F&#x2010;labeled tubastatin A analog for PET imaging of histone deacetylase 6. Journal of Labelled Compounds and Radiopharmaceuticals, 63(2), 85&#x2013;95. 10.1002/jlcr.3823</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlcr.3823</ArticleId><ArticleId IdType="pubmed">31881107</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, B. L. (2017). Could sirtuin activities modify ALS onset and progression? Cellular and Molecular Neurobiology, 37(7), 1147&#x2013;1160. 10.1007/s10571-016-0452-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-016-0452-2</ArticleId><ArticleId IdType="pubmed">27942908</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas, E. A. , &amp; D'Mello, S. R. (2018). Complex neuroprotective and neurotoxic effects of histone deacetylases. Journal of Neurochemistry, 145(2), 96&#x2013;110. 10.1111/jnc.14309</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14309</ArticleId><ArticleId IdType="pmc">PMC5920706</ArticleId><ArticleId IdType="pubmed">29355955</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani, M. , Tradewell, M. L. , Mattina, K. R. , Minotti, S. , Yang, W. , Zhou, H. , &#x2026; Durham, H. D. (2015). Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1. Human Molecular Genetics, 24(3), 773&#x2013;786. 10.1093/hmg/ddu494</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu494</ArticleId><ArticleId IdType="pmc">PMC4291251</ArticleId><ArticleId IdType="pubmed">25274782</ArticleId></ArticleIdList></Reference><Reference><Citation>Valle, C. , Salvatori, I. , Gerbino, V. , Rossi, S. , Palamiuc, L. , Ren&#xe9;, F. , &amp; Carr&#xec;, M. T. (2014). Tissue&#x2010;specific deregulation of selected HDACs characterizes ALS progression in mouse models: Pharmacological characterization of SIRT1 and SIRT2 pathways. Cell Death &amp; Disease, 5(6), 1&#x2013;10. 10.1038/cddis.2014.247</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.247</ArticleId><ArticleId IdType="pmc">PMC4611720</ArticleId><ArticleId IdType="pubmed">24946089</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme, P. , Robberecht, W. , &amp; Van Den Bosch, L. (2017). Modelling amyotrophic lateral sclerosis: Progress and possibilities. DMM Disease Models and Mechanisms, 10(5), 537&#x2013;549. 10.1242/dmm.029058</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.029058</ArticleId><ArticleId IdType="pmc">PMC5451175</ArticleId><ArticleId IdType="pubmed">28468939</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance, C. , Rogelj, B. , Hortob&#xe1;gyi, T. , De Vos, K. J. , Nishimura, A. L. , Sreedharan, J. , &#x2026; Shaw, C. E. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science, 323(5918), 1208&#x2013;1211. 10.1126/science.1165942</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne, T. , De Bock, K. , &amp; Van Den Bosch, L. (2018). Energy metabolism in ALS: An underappreciated opportunity? Acta Neuropathologica, 135(4), 489&#x2013;509. 10.1007/s00401-018-1835-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Vega, R. B. , Matsuda, K. , Oh, J. , Barbosa, A. C. , Yang, X. , Meadows, E. , &#x2026; Olson, E. N. (2004). Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell, 119(4), 555&#x2013;566. 10.1016/j.cell.2004.10.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.10.024</ArticleId><ArticleId IdType="pubmed">15537544</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen, K. , Ahamed, M. , Luyten, K. , &amp; Bormans, G. (2019). Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma. Nuclear Medicine and Biology, 74&#x2013;75, 1&#x2013;11. 10.1016/j.nucmedbio.2019.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nucmedbio.2019.05.004</ArticleId><ArticleId IdType="pubmed">31421440</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, C. , Schroeder, F. A. , Wey, H. Y. , Borra, R. , Wagner, F. F. , Reis, S. , &#x2026; Hooker, J. M. (2014). In vivo imaging of histone deacetylases (HDACs) in the central nervous system and major peripheral organs. Journal of Medicinal Chemistry, 57(19), 7999&#x2013;8009. 10.1021/jm500872p</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm500872p</ArticleId><ArticleId IdType="pmc">PMC4191584</ArticleId><ArticleId IdType="pubmed">25203558</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, J. , Zhang, Y. , Tang, L. , Zhang, N. , &amp; Fan, D. (2011). Protective effects of resveratrol through the up&#x2010;regulation of SIRT1 expression in the mutant hSOD1&#x2010;G93A&#x2010;bearing motor neuron&#x2010;like cell culture model of amyotrophic lateral sclerosis. Neuroscience Letters, 503(3), 250&#x2013;255. 10.1016/j.neulet.2011.08.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2011.08.047</ArticleId><ArticleId IdType="pubmed">21896316</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, W. Y. , Pan, L. , Su, S. C. , Quinn, E. J. , Sasaki, M. , Jimenez, J. C. , &#x2026; Tsai, L. H. (2013). Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nature Neuroscience, 16(10), 1383&#x2013;1391. 10.1038/nn.3514</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3514</ArticleId><ArticleId IdType="pmc">PMC5564396</ArticleId><ArticleId IdType="pubmed">24036913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, X. , Arai, S. , Song, X. , Reichart, D. , Du, K. , Pascual, G. , &#x2026; Kurokawa, R. (2008). Induced ncRNAs allosterically modify RNA&#x2010;binding proteins in cis to inhibit transcription. Nature, 454(7200), 126&#x2013;130. 10.1038/nature06992</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06992</ArticleId><ArticleId IdType="pmc">PMC2823488</ArticleId><ArticleId IdType="pubmed">18509338</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe, S. , Ageta&#x2010;Ishihara, N. , Nagatsu, S. , Takao, K. , Komine, O. , Endo, F. , &#x2026; Yamanaka, K. (2014). SIRT1 overexpression ameliorates a mouse model of SOD1&#x2010;linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system. Molecular Brain, 7(1), 1&#x2013;11. 10.1186/s13041-014-0062-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-014-0062-1</ArticleId><ArticleId IdType="pmc">PMC4237944</ArticleId><ArticleId IdType="pubmed">25167838</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, A. H. , Valdez, G. , Moresi, V. , Qi, X. , Mcanally, J. , Elliott, J. L. , &#x2026; Olson, E. N. (2009). MicroRNA&#x2010;206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science, 358(December), 1549&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo, Y. E. , &amp; Ko, C. P. (2011). Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. Experimental Neurology, 231(1), 147&#x2013;159. 10.1016/j.expneurol.2011.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.06.003</ArticleId><ArticleId IdType="pubmed">21712032</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, H. , Lu, S. , Gasior, K. , Singh, D. , Tapia, O. , Toprani, D. , Beccari, M. S. , Newby, J. M. , Larfaga, M. , Gladfelter, A. S. , Villa, E. , &amp; Cleveland, D. W. (2020). TDP&#x2010;43 and HSP70 phase separate into anisotropic, intranuclear liquid spherical annuli. Biorxiv.Org.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286096</ArticleId><ArticleId IdType="pubmed">33335017</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, L. , Zhang, J. , Jiang, Q. , Zhang, L. , &amp; Song, W. (2018). Zinc binding groups for histone deacetylase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 33(1), 714&#x2013;721. 10.1080/14756366.2017.1417274</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756366.2017.1417274</ArticleId><ArticleId IdType="pmc">PMC6009916</ArticleId><ArticleId IdType="pubmed">29616828</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X. , Yuan, Z. , Zhang, Y. , Yong, S. , Salas&#x2010;burgos, A. , Koomen, J. , &#x2026; Seto, E. (2007). HDAC6 modulates cell motility by altering the acetylation level of cortactin. Molecular Cell, 27(2), 197&#x2013;213. 10.1016/j.molcel.2007.05.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2007.05.033</ArticleId><ArticleId IdType="pmc">PMC2684874</ArticleId><ArticleId IdType="pubmed">17643370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y. , Kwon, S. , Yamaguchi, T. , Cubizolles, F. , Rousseaux, S. , Kneissel, M. , &#x2026; Matthias, P. (2008). Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Molecular and Cellular Biology, 28(5), 1688&#x2013;1701. 10.1128/MCB.01154-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01154-06</ArticleId><ArticleId IdType="pmc">PMC2258784</ArticleId><ArticleId IdType="pubmed">18180281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu, Y. , Vidaurre, O. G. , Adula, K. P. , Kezunovic, N. , Wentling, M. , Huntley, G. W. , &amp; Casaccia, P. (2017). Subcellular distribution of HDAC1 in neurotoxic conditions is dependent on serine phosphorylation. Journal of Neuroscience, 37(31), 7547&#x2013;7559. 10.1523/JNEUROSCI.3000-16.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3000-16.2017</ArticleId><ArticleId IdType="pmc">PMC5546117</ArticleId><ArticleId IdType="pubmed">28663197</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>